Showing results (1921-1930 of 1,960) with videos related to

Sort By:
Pageof 196
American Journal of Hematology|October 23, 2015
Personalized risk prediction for event-free survival at 24 months in patients with diffuse large B-cell lymphomaMatthew J Maurer, Jean-Philippe Jais, Hervé Ghesquières, et al.
Nature Communications|September 7, 2017
A potent series targeting the malarial cGMP-dependent protein kinase clears infection and blocks transmissionDavid A Baker, Lindsay B Stewart, Jonathan M Large, et al.
Neuro-Oncology|July 18, 2022
Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trialAndrew B Lassman, Stephanie L Pugh, Tony J C Wang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 11, 2022
T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in OncologySteven M Horwitz, Stephen Ansell, Weiyun Z Ai, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 21, 2012
Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencingJens G Lohr, Petar Stojanov, Michael S Lawrence, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 26, 2019
Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular TherapyTania Jain, Merav Bar, Ankit J Kansagra, et al.
Blood|April 21, 2017
Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLLWei Ding, Betsy R LaPlant, Timothy G Call, et al.
Journal of Evolutionary Biology|January 18, 2013
Hybridization and speciationR Abbott, D Albach, S Ansell, et al.
The New England Journal of Medicine|September 29, 2019
Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian CancerRobert L Coleman, Gini F Fleming, Mark F Brady, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 1, 2023
Response to COVID-19 Vaccination Post-CAR T Therapy in Patients With Non-Hodgkin Lymphoma and Multiple MyelomaJulia E Wiedmeier-Nutor, Madiha Iqbal, Allison C Rosenthal, et al.
Pageof 196